Semnur Pharmaceuticals, Inc. (SMNR, SMNRW) — SEC 8-K Filing
Semnur Pharmaceuticals
Mar 17, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Tracking 234 other M&A deals. Browse other transactions across all sectors and states.
Semnur Pharmaceuticals
Mar 17, 2026
Alcon Research→LENSAR
Mar 17, 2026
Aquatic Capital Management→Kinsale Capital Group
Mar 16, 2026
Abra
Mar 16, 2026
Pony Testing
Mar 15, 2026
Mar 13, 2026
Meridiem Capital Partners→Global Payments
Mar 13, 2026
New Mountain Finance
Mar 13, 2026
Terra Property Trust
Mar 12, 2026
Sonida Senior Living
Mar 11, 2026
PactFi
Mar 10, 2026
NexGel
Mar 10, 2026
CMS Info Systems→Securens Systems
Mar 9, 2026
Northrim BanCorp
Mar 9, 2026
Netflix→InterPositive
Mar 6, 2026
Robinhood Markets→Robinhood Ventures Fund I
Mar 6, 2026
SL Green Realty
Mar 6, 2026
T Stamp→Lexverify
Mar 5, 2026
Thor Equities→139 Fifth Avenue
Mar 3, 2026
Sarasota family office
Mar 3, 2026